Last --
Change Today 0.00 / 0.00%
Volume 0.0
1112 On Other Exchanges
1112 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

biostime international holdi (1112) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BIOSTIME INTERNATIONAL HOLDI (1112)

Related News

No related news articles were found.

biostime international holdi (1112) Related Businessweek News

No Related Businessweek News Found

biostime international holdi (1112) Details

Biostime International Holdings Limited, an investment holding company, is engaged in the research, development, manufacture, and sale of pediatric nutritional and baby care products primarily in the People’s Republic of China. The company operates through four segments: Infant Formulas, Probiotic Supplements, Dried Baby Food and Nutrition Supplements, and Baby Care Products. The Infant Formulas segment produces infant formulas for children under seven years old; and milk formulas for expectant and nursing mothers. The Probiotic Supplements segment offers probiotic supplements in the form of sachets, capsules, and tablets for infants, children, and expectant mothers. The Dried Baby Food and Nutrition Supplements segment is engaged in the production of dried baby food products made from natural foods for infants and young children; microencapsulated milk calcium chewable tablets and DHA chews/soft capsules for children, and pregnant and lactating mothers. The Baby Care Products segment provides baby care products for infants and children, including baby diapers and toiletry kits, as well as personal care products for nursing mothers, such as nursing pads. Biostime International Holdings Limited is also involved in the wholesale, retail, import, and export of personal care products for infants; trading of infant food and nutritional products; early childhood education advisory business; and trading of related baby supplies. It sells its products and services under the Biostime, Adimil, BMcare, Parenting Power, and Mama100 brand names. The company was founded in 1999 and is headquartered in Guangzhou, China. Biostime International Holdings Limited is a subsidiary of Biostime Pharmaceuticals (China) Limited.

3,000 Employees
Last Reported Date: 04/2/14
Founded in 1999

biostime international holdi (1112) Top Compensated Officers

Chairman, Chief Executive Officer, Chairman o...
Total Annual Compensation: CNY7.8M
Chief Operating Officer and Executive Directo...
Total Annual Compensation: CNY5.5M
Compensation as of Fiscal Year 2013.

biostime international holdi (1112) Key Developments

Biostime International Holdings Limited (China) Announces Consolidated Earnings Results for the Year Ended 31 December 2013

Biostime International Holdings Limited (China) announced consolidated earnings results for the year ended 31 December 2013. For the year, the company reported revenue was RMB 4,561.3 million against RMB 3,381.9 million a year ago. Profit before tax was RMB 1,162.1 million against RMB 1,050.57 million a year ago. Profit attributable to owners of the parent was RMB 820.71 million against RMB 743.11 million a year ago. Diluted earnings per share were RMB 1.34 against RMB 1.22 a year ago. Capital expenditure was RMB 342.26 million against RMB 60.69 million a year ago. Purchase of property, plant and equipment was RMB 135.7 million. Excluding the one-off expense, net profit was at a record amount of RMB 983.6 million.

Biostime International Holdings Limited Recommends Final and Special Dividend Payable on or About May 27, 2014

Biostime International Holdings Limited announced that the Board has recommended the payment of a final dividend of HKD 0.44 per ordinary share and a final special dividend of HKD 0.33 per ordinary share for the year ended December 31, 2013. Taking into account the interim dividend and interim special dividend of HKD 0.25 and HKD 0.19 per ordinary share paid in September 2013, the annual dividends for the year ended December 31, 2013 will amount to HKD 1.21 per ordinary share, accounting for approximately 70.3% of profit for the year ended December 31, 2013. Subject to the approval of shareholders at the forth coming annual general meeting to be held on May 8, 2014, the final dividend and special dividend will be paid on or about May 27, 2014 to the share holders whose names appear on the register of members of the company on May 16, 2014.

Biostime International Holdings Limited (China) to Report Fiscal Year 2013 Results on Mar 25, 2014

Biostime International Holdings Limited (China) announced that they will report fiscal year 2013 results on Mar 25, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
1112:HK $50.80 HKD -1.05

1112 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1112.
View Industry Companies

Industry Analysis


Industry Average

Valuation 1112 Industry Range
Price/Earnings 29.6x
Price/Sales 5.2x
Price/Book 9.5x
Price/Cash Flow 29.1x
TEV/Sales 4.7x

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOSTIME INTERNATIONAL HOLDI, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at